The Medical Letter on Drugs and Therapeutics
October 8, 2018
Choice of Contraceptives
|Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article.|
Choice of Contraceptives
October 8, 2018 (Issue: 1557)
- ARA Aiken and J Trussell. Recent advances in contraception. F1000Prime Rep 2014; 6:113.
- J Trussell and ARA Aiken. Contraceptive efficacy. In: RA Hatcher et al. Contraceptive Technology: Twenty-first revised edition. New York, NY: Ayer Company Publishers 2018.
- KM Curtis et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016; 65:1.
- MF Gallo et al. 20 μg versus >20 μg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev 2013; 8:CD003989.
- A Edelman et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev 2014; 7:CD004695.
- L Iversen et al. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ 2018; 362:k3609.
- AR Brant et al. Non-contraceptive benefits of hormonal contraception: established benefits and new findings. Curr Obstet Gynecol Rep 2017; 6:109.
- R Słopień et al. Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age. Menopause Rev 2018; 17:1.
- Three new oral contraceptives. Med Lett Drugs Ther 2006; 48:77.
- MK Trivedi et al. A review of hormone-based therapies to treat adult acne vulgaris in women. Int J Womens Dermatol 2017; 3:44.
- Y Vinogradova et al. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2015; 350:h2135.
- C Oedingen et al. Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose. Thromb Res 2018; 165:68.
- LS Mørch et al. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 2017; 377:2228.
- CW Skovlund et al. Association of hormonal contraception with depression. JAMA Psychiatry 2016; 73:1154.
- FDA. Labeling for combined hormonal contraceptives: guidance for industry. December 2017. Available at www.fda.gov. Accessed September 27, 2018.
- KB Simmons et al. Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review. Am J Obstet Gynecol 2018; 218:88.
- ACOG. Committee opinion No. 602: depot medroxyprogesterone acetate and bone effects. Obstet Gynecol 2014; 123:1398.
- ACOG. Practice bulletin No. 186: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2017; 130:e251.
- In brief: etonogestrel (Nexplanon) contraceptive implant. Med Lett Drugs Ther 2012; 54:12.
- KM Curtis and JF Peipert. Long-acting reversible contraception. N Engl J Med 2017; 376:461.
- JP Wu et al. Long-acting reversible contraception - highly efficacious, safe, and underutilized. JAMA 2018; 320:397.
- VK Cortessis et al. Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis. Obstet Gynecol 2017; 130:1226.
- I Sivin. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception 2007; 75(6 Suppl):S70.
- Liletta - a third levonorgestrel-releasing IUD. Med Lett Drugs Ther 2015; 57:99.
- Kyleena - another hormonal IUD. Med Lett Drugs Ther 2017; 59:38.
- ACOG. Practice bulletin summary No. 152: emergency contraception. Obstet Gynecol 2015; 126:685.
- ND Goldstuck and D Wildemeersch. Practical advice for emergency IUD contraception in young women. Obstet Gynecol Int 2015; 2015:986439.
- DT Baird. Emergency contraception: how does it work? Reprod Biomed Online 2009; 18 Suppl 1:32.
- A Glasier. The rationale for use of ulipristal acetate as first line in emergency contraception: biological and clinical evidence. Gynecol Endocrinol 2014; 30:688.
- G Piaggio et al. Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. Contraception 2011; 84:35.
- K Cleland et al. Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol 2014; 57:741.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.